Central Queensland University, The Appleton Institute for Behavioural Science, Adelaide, South Australia.
Whoop Inc., Data Science & Research, Boston, Massachusetts, United States of America.
PLoS One. 2020 Dec 10;15(12):e0243693. doi: 10.1371/journal.pone.0243693. eCollection 2020.
COVID-19, the disease caused by the SARS-CoV-2 virus, can cause shortness of breath, lung damage, and impaired respiratory function. Containing the virus has proven difficult, in large part due to its high transmissibility during the pre-symptomatic incubation. The study's aim was to determine if changes in respiratory rate could serve as a leading indicator of SARS-CoV-2 infections. A total of 271 individuals (age = 37.3 ± 9.5, 190 male, 81 female) who experienced symptoms consistent with COVID-19 were included- 81 tested positive for SARS-CoV-2 and 190 tested negative; these 271 individuals collectively contributed 2672 samples (days) of data (1856 healthy days, 231 while infected with COVID-19 and 585 while negative for COVID-19 but experiencing symptoms). To train a novel algorithm, individuals were segmented as follows; (1) a training dataset of individuals who tested positive for COVID-19 (n = 57 people, 537 samples); (2) a validation dataset of individuals who tested positive for COVID-19 (n = 24 people, 320 samples); (3) a validation dataset of individuals who tested negative for COVID-19 (n = 190 people, 1815 samples). All data was extracted from the WHOOP system, which uses data from a wrist-worn strap to produce validated estimates of respiratory rate and other physiological measures. Using the training dataset, a model was developed to estimate the probability of SARS-CoV-2 infection based on changes in respiratory rate during night-time sleep. The model's ability to identify COVID-positive individuals not used in training and robustness against COVID-negative individuals with similar symptoms were examined for a critical six-day period spanning the onset of symptoms. The model identified 20% of COVID-19 positive individuals in the validation dataset in the two days prior to symptom onset, and 80% of COVID-19 positive cases by the third day of symptoms.
新型冠状病毒肺炎(COVID-19)是由严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起的疾病,可导致呼吸急促、肺部损伤和呼吸功能受损。由于该病毒在症状前潜伏期内具有高度传染性,因此控制其传播极具挑战性。本研究旨在确定呼吸频率的变化是否可以作为 SARS-CoV-2 感染的早期指标。共纳入 271 名出现 COVID-19 症状的个体(年龄=37.3±9.5,190 名男性,81 名女性),其中 81 名 SARS-CoV-2 检测呈阳性,190 名检测呈阴性;这 271 名个体共提供了 2672 份(天)数据(1856 天健康,231 天感染 COVID-19,585 天 COVID-19 检测阴性但出现症状)。为了训练一种新算法,将个体分为以下几类:(1)COVID-19 检测呈阳性的个体训练数据集(n=57 人,537 个样本);(2)COVID-19 检测呈阳性的个体验证数据集(n=24 人,320 个样本);(3)COVID-19 检测阴性的个体验证数据集(n=190 人,1815 个样本)。所有数据均从 WHOOP 系统中提取,该系统使用腕带数据生成经验证的呼吸频率和其他生理指标估计值。使用训练数据集,开发了一种基于夜间睡眠期间呼吸率变化来估计 SARS-CoV-2 感染概率的模型。在出现症状的六天关键期间,检查了该模型识别未用于训练的 COVID-19 阳性个体的能力以及对具有相似症状的 COVID-19 阴性个体的稳健性。该模型在症状出现前的前两天内识别出验证数据集中 20%的 COVID-19 阳性个体,在出现症状的第三天识别出 80%的 COVID-19 阳性个体。
Cochrane Database Syst Rev. 2020-9-30
Infect Dis Poverty. 2020-12-2
J Med Internet Res. 2020-9-9
Pediatr Allergy Immunol. 2020-6-18
Ann Clin Microbiol Antimicrob. 2020-12-7
Biomed Opt Express. 2025-6-20
J Med Internet Res. 2025-3-26
Micromachines (Basel). 2024-7-31
Front Netw Physiol. 2024-6-14
BMC Med Inform Decis Mak. 2024-6-24
Nat Med. 2020-4-15
Int J Antimicrob Agents. 2020-2-17
J Travel Med. 2020-3-13
J Clin Sleep Med. 2020-5-15
N Engl J Med. 2020-3-5
Am Fam Physician. 2007-8-15